Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies
Ziyu Ji, Jianlin Shen, Yujian Lan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Osteosarcoma in a ceRNET perspective
Nicola Mosca, Nicola Alessio, Alessandra Di Paola, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 5
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma
Yan Peng, Jie Wang, Bin Yue, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189171-189171
Closed Access | Times Cited: 5
Research progress on N6-methyladenosine RNA modification in osteosarcoma: functions, mechanisms, and potential clinical applications
Ying Yang, Wenjuan Ni, Yadong Yang, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma
Shibing Zhao, Dasheng Tian, Fei Huang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance
Shaoyan Shi, Xuehai Ou, Chao Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
7-Geranyloxycoumarin modulated metastatic potential of osteosarcoma cells via interaction with MMPs and JAK1/2
Fatemehsadat Hosseini, Abdolreza Ahmadi, Zahra Nasiri Sarvi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Identifying KDM5B as the synthetic lethal target of KMT2D-mutated osteosarcoma
Liyu Yang, Jing Zhang, Yiting Jiang, et al.
Chemico-Biological Interactions (2025), pp. 111451-111451
Closed Access
The Role of Epithelial–Mesenchymal Transition in Osteosarcoma Progression: From Biology to Therapy
Adriana Pătrașcu, Elena Ţarcă, Ludmila Lozneanu, et al.
Diagnostics (2025) Vol. 15, Iss. 5, pp. 644-644
Open Access
Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations
Nojoud Al-Ansari, Samson Mathews Samuel, Dietrich Büsselberg
Biomolecules (2024) Vol. 14, Iss. 2, pp. 145-145
Open Access | Times Cited: 3
Role of proteoglycan synthesis genes in osteosarcoma stem cells
Ryoma Osumi, K. Sugihara, Makoto Yoshimoto, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma
Jiatong Li, Yang Bai, He Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Bone Healing via Carvacrol and Curcumin Nanoparticle on 3D Printed Scaffolds
Aditi Dahiya, Vishal Sharad Chaudhari, Susmita Bose
Small (2024)
Open Access | Times Cited: 2
Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma—A Narrative Review
Yuanrui Luo, M. Sun, Linyun Tan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2717-2717
Open Access | Times Cited: 7
Advances in Target Therapy Research in Osteosarcoma
Caterina Chiappetta, Carlo Della Rocca, Claudio Di Cristofano
(2024)
Open Access | Times Cited: 1
Comprehensive analysis of the clinical significance and molecular mechanism of T-box transcription factor 3 in osteosarcoma
Yu-Nan Man, Hua Xu, Pei-Jun Chen, et al.
Journal of Cancer (2024) Vol. 15, Iss. 12, pp. 4007-4019
Open Access | Times Cited: 1
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
Weilin Shao, Yan Feng, Jin Huang, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Ubiquitination in osteosarcoma: unveiling the impact on cell biology and therapeutic strategies
Jianlin Shen, Yue Lai, Yanjiao Wu, et al.
Cancer Biology and Medicine (2024) Vol. 21, Iss. 10, pp. 880-897
Open Access | Times Cited: 1
SQLE promotes osteosarcoma progression via activating TGFβ/SMAD signaling pathway
Song Qi, Lina He, Jing Feng
Molecular and Cellular Probes (2024) Vol. 78, pp. 101993-101993
Open Access | Times Cited: 1
Research Progress of Non Coding RNA Related to Notch Signaling Pathway in Osteosarcoma
文强 李
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 3011-3017
Closed Access
Deciphering the prognostic landscape of osteosarcoma: Integrating the roles of hippo pathway genes, programmed cell death, and the tumor immune microenvironment
Huayan Ma, Yuxian Zhang, Jing Li, et al.
Environmental Toxicology (2024)
Closed Access
Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway
Liujing Qu, Xin Yu, Jieni Feng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Surface Engineered Osteoblast-Extracellular Vesicles Serve as an Efficient Carrier for Drug and Small RNA to Actively Target Osteosarcoma
Sasmita Samal, Gyanendra Prasad Panda, S. Shyamal, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 12, pp. 7466-7481
Closed Access
Nanomaterials for biomedical applications
Bhavana Raj, Kaladhar Kamalasanan
Elsevier eBooks (2024), pp. 107-139
Closed Access
Trends and future directions of autophagy in osteosarcoma: A bibliometric analysis
JinXiang Shang, Fen Zhao, Lu Xie, et al.
Open Medicine (2024) Vol. 19, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top